Displaying 1–15 of 15 results for Deloitte Life Sciences

Sort By Relevance Sort By Date

Modernizing manufacturing through a connected shop floor

(Article)

Eliminating siloed systems in favor of streamlined applications allows for greater agility and stronger collaboration, enabling pharma to meet the new quality management demands

The Changing Biopharma Risk Equation

(Article)

Multinational survey of pharma execs offers insight on pharmaceutical companies’ growth strategies and risk management in the challenging biologics landscape

Veeva Systems Named a CRM Leader by Nucleus Research for the Second ...

(News)

For the second consecutive year, Veeva Systems has been named a Leader by Nucleus Research in its 2014 Technology Value Matrix for customer relationship management (CRM).

Rapid Micro Biosystems Names New CEO

(News)

The company has appointed industry veteran Robert Spignesi as its chief executive officer

Track and Trace Gains Prominence in the War Against Counterfeit Drugs

(Article)

Regulation and technology lead the fight against counterfeit pharmaceuticals.

Is Pharma Stuck on the Way to Six Sigma?

(Article)

Six Sigma and OpEx now take a back seat to cost-cutting, yet experts say cost reduction will, ultimately, drive the industry’s transformation

The Future of the Life Sciences Industries: Transformation Amid Rising Risk

(Whitepaper)

This white paper by Deloitte Touche Tohmatsu developed in collaboration with the Economist Intelligence Unit (EIU), addresses the growing risks in the life sciences industry and examines how companies will manage and deal with these risks in these changing times.

Tech Transfer: Don't Fumble the Hand Off

(Article)

Technology transfer was once taken for granted as something that would “get done anyway.” Now it’s an indicator of manufacturing excellence and a core competency for drug innovators.

Global Security Study: Perspectives for Life Sciences

(Whitepaper)

While facing an era of new regulatory and marketplace pressures, the life sciences industry is placing more emphasis on the areas of security, information protection and data privacy issues within their organizations. Two key findings: The number of major life sciences firms that employ chief ...

IT and Data Security: Deloitte Assesses Pharma's Readiness

(Whitepaper)

Deloitte Touche Tohmatsu (DTT) surveyed a global representation of leading life sciences executives to determine the security issues facing the industry. The resulting study presents industry trends, security considerations that go beyond the realm of IT, and issues such as business continuity ...

All Aboard the Cold Chain

(Article)

Pharmaceutical processing & engineering: As liability risks increase, drug manufacturers are assuming greater ownership of the “cold chain” for transporting valuable biologics.

Making Sense of Sarbanes-Oxley | Pharmaceutical Manufacturing

(Article)

SOX is moving from the executive suite down to the plant floor.

The Future of Drugmaking

(Article)

Throwing it All Away

(Article)

Sort By Relevance Sort By Date